Загрузка...
Reducing toxicity of 4–1BB costimulation: targeting 4–1BB ligands to the tumor stroma with bi-specific aptamer conjugates
Systemic administration of immune modulatory antibodies to cancer patients is associated with autoimmune pathologies. We have developed a clinically feasible and broadly applicable approach to limit immune stimulation to disseminated tumor lesions using a bi-specific agonistic 4–1BB oligonucleotide...
Сохранить в:
| Опубликовано в: : | Oncoimmunology |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404909/ https://ncbi.nlm.nih.gov/pubmed/25949891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.970918 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|